| Article name | Product# | Method | Purposes | |
|---|---|---|---|---|
| RIASON Glucagon | R05-022-050 | RIA | 50 | |
| RIASON® anti-GAD 100 | R05-080-100AJ | RIA | 100 | IFU |
| RIASON® anti-GAD 50 | R05-080-50AJ | RIA | 50 | IFU |
| RIASON® anti- IA2 100 | R05-081-100AJ | RIA | 100 | IFU |
| RIASON® anti- IA2 50 | R05-081-50AJ | RIA | 50 | IFU |
| RIASON® anti-IAA 100 | R05-082-100AJ | RIA | 100 | IFU |
| RIASON® anti-IAA 50 | R05-082-50AJ | RIA | 50 | IFU |
| RIASON Leptin | R05-085-125 | RIA | 125 | |
| RIASON C-Peptid | R05-088-100 | RIA | 100 | |
| RIASON Glucagon | R05-089-250 | RIA | 250 | |
| RIASON® Insulin | R05-090-100 | RIA | 100 |
30.04.2012 08:00
Dates for our next congresses
We would be very pleased to welcome you at our booth on one of the next congresses!
03.02.2012 11:00
IASON pharmaceutical production site opened in Kielce, Poland
On 2nd of February 2012, the pharmaceutical production site in Kielce, Poland was officially opened...
26.08.2011 14:00
IASOcholine: New authorization in Germany and Austria!
We are happy to announce that from now on our product IASOcholine® is also available for the German...
